Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mitsuaki Ohtani is active.

Publication


Featured researches published by Mitsuaki Ohtani.


Journal of Medicinal Chemistry | 2003

Synthesis and Biological Activity of Various Derivatives of a Novel Class of Potent, Selective, and Orally Active Prostaglandin D2 Receptor Antagonists. 2. 6,6-Dimethylbicyclo[3.1.1]heptane Derivatives

Susumu Mitsumori; Tatsuo Tsuri; Tsunetoshi Honma; Yoshiharu Hiramatsu; Toshihiko Okada; Hiroshi Hashizume; Shiro Kida; Masanao Inagaki; Akinori Arimura; Kiyoshi Yasui; Fujio Asanuma; Junji Kishino; Mitsuaki Ohtani

In an earlier paper, we reported that novel prostaglandin D(2) (PGD(2)) receptor antagonists having the bicyclo[2.2.1]heptane ring system as a prostaglandin skeleton were a potent new class of antiallergic agents and suppressed various allergic inflammatory responses such as those observed in conjunctivitis and asthma models. In the present study, we synthesized PGD(2) receptor antagonists having the 6,6-dimethylbicyclo[3.1.1]heptane ring system. These derivatives have the amide moiety, in contrast to those with the bicyclo[2.2.1]heptane ring system, which have the sulfonamide group. The derivatives having the 6,6-dimethylbicyclo[3.1.1]heptane ring also exhibited strong activity in PGD(2) receptor binding and cAMP formation assays. In in vivo assays such as allergic rhinitis, conjunctivitis, and asthma models, these series of derivatives showed excellent pharmacological profiles. In particular, compound 45 also effectively suppressed eosinophil infiltration in allergic rhinitis and asthma models. This compound (45, S-5751) is now being developed as a promising alternative antiallergic drug candidate.


FEBS Letters | 1992

Contraction of guinea pig lung parenchyma by pancreatic type phospholipase A2 via its specific binding site

Toshiyuki Kanemasa; Akinori Arimura; Junji Kishino; Mitsuaki Ohtani; Hitoshi Arita

Porcine pancreatic group I phospholipase A2 (PLA2‐I) induced contraction of guinea pig lung parenchyma in a concentration‐dependent manner. Its EC50 value was similar to theK d value calculated from the specific binding of125I‐labeled porcine PLA2‐I in the membrane fraction of guinea pig lung. Type‐specific action of PLA2s and homologous desensitization strongly implicated the involvement of PLA2‐I‐specific sites in the activation process. Throm☐ane A2 was found to be the main product from lung tissue by PLA2‐I action and the contractile response by PLA2‐I was specifically suppressed by throm☐ane A2 receptor antagonists and cyclooxygenase inhibitor, but not by leukotriene receptor antagonist and H1 blocker. These findings indicate that PLA2‐I‐induced contractile response may depend on the secondarily produced throm☐ane A2, thus providing a new aspect of PLA2‐I from the pathophysiological standpoint.


Tetrahedron Letters | 1989

Enantiospecific synthesis of a rigid, C2 symmetric, chiral guanidine by a new and direct method

E. J. Corey; Mitsuaki Ohtani

Abstract A broadly applicable method has been demonstrated for the efficient synthesis of chiral bicyclic guanidines such as 1 from chiral α-amino acids.


Angewandte Chemie | 1998

Total Synthesis of Terprenin, a Highly Potent and Novel Immunoglobulin E Antibody Suppressant

Kenji Kawada; Akinori Arimura; Tatsuo Tsuri; Masahiro Fuji; Tadafumi Komurasaki; Shuji Yonezawa; Akira Kugimiya; Nobuhiro Haga; Susumu Mitsumori; Masanao Inagaki; Takuji Nakatani; Yoshinori Tamura; Shozo Takechi; Teruhiko Taishi; Junji Kishino; Mitsuaki Ohtani

Regioselective halogenations and Suzuki reactions ensure proper linkage of the aromatic rings in two total syntheses of terprenin (1). Both routes make it possible to prepare 1 efficiently and in large quantity.


European Journal of Medicinal Chemistry | 2000

New γ-fluoromethotrexates modified in the pteridine ring: synthesis and in vitro immunosuppressive activity

Yoshitsugu Kokuryo; Takuji Nakatani; Makoto Kakinuma; Mikio Kabaki; Kyozo Kawata; Akira Kugimiya; Kenji Kawada; Mitsunobu Matsumoto; Ryuji Suzuki; Mitsuaki Ohtani

Our continuing program to develop new antifolate drugs useful against rheumatoid arthritis led us to modify the pteridine ring of gamma-fluoromethotrexate. Pyrrolopyrimidine derivatives 1e and 1t were found to exhibit potent suppressive effects on the responses of both T and B cells to mitogens, although tetrahydropyridopyrimidine derivatives 2e and 2t and quinazoline derivatives 3e, 3t and 4e showed very weak suppressive activities. Thus, conversion of the pteridine ring of gamma-fluoromethotrexate to a pyrrolopyrimidine ring led to a new potential antirheumatic compound.


Tetrahedron-asymmetry | 1996

Practical synthesis of L-erythro- and L-threo-4-fluoroglutamic acids using aminoacylase

Yoshitsugu Kokuryo; Takuji Nakatani; Kobee Kobayashi; Yoshinori Tamura; Kenji Kawada; Mitsuaki Ohtani

Abstract Enantiomerically pure L- erythro - and L- threo -4-fluoroglutamic acids 1a and 1b were conveniently prepared. The key steps in this synthesis relied upon separation of diastereomers of N -chloroacetyl-4-fluoroglutamic acid 5-methyl ester 7 by recrystallization and enzymatic resolution of enantiomers of the resulting 7(a+c) and 7(b+d) by aminoacylase. Protection of the γ-carboxyl group as a methyl ester was found to be crucial for this enzymatic reaction.


Angewandte Chemie | 1998

Totalsynthese von Terprenin, einem hochwirksamen Immunglobulin-E-Suppressivum

Kenji Kawada; Akinori Arimura; Tatsuo Tsuri; Masahiro Fuji; Tadafumi Komurasaki; Shuji Yonezawa; Akira Kugimiya; Nobuhiro Haga; Susumu Mitsumori; Masanao Inagaki; Takuji Nakatani; Yoshinori Tamura; Shozo Takechi; Teruhiko Taishi; Junji Kishino; Mitsuaki Ohtani

Regioselektive Halogenierungen und Suzuki-Reaktionen ermoglichen die richtige Verknupfung der aromatischen Ringe in zwei Totalsynthesen von Terprenin 1. Durch beide Reaktionswege kann 1 effizient und in groserer Menge erhalten werden.


Journal of Medicinal Chemistry | 1998

Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2): N-Sulfonylamino Acid Derivatives

Yoshinori Tamura; Fumihiko Watanabe; Takuji Nakatani; Ken Yasui; Masahiro Fuji; Tadafumi Komurasaki; Hiroshige Tsuzuki; Ryuji Maekawa; Takayuki Yoshioka; Kenji Kawada; and Kenji Sugita; Mitsuaki Ohtani


Journal of Medicinal Chemistry | 1996

Potent Inhibitors of Secretory Phospholipase A2: Synthesis and Inhibitory Activities of Indolizine and Indene Derivatives

Sanji Hagishita; Masaaki Yamada; Kazuhiro Shirahase; Toshihiko Okada; Yasushi Murakami; Yuji Ito; Takaharu Matsuura; Masaaki Wada; Toshiyuki Kato; Masahiko Ueno; Yukiko Chikazawa; Katsutoshi Yamada; Takashi Ono; Isao Teshirogi; Mitsuaki Ohtani


Journal of Medicinal Chemistry | 2000

Pyrrolidine inhibitors of human cytosolic phospholipase A2

Kaoru Seno; Takayuki Okuno; Koichi Nishi; Yasushi Murakami; Fumihiko Watanabe; Takaharu Matsuura; Masaaki Wada; Yasuhiko Fujii; Masaaki Yamada; Tomoyuki Ogawa; Tetsuo Okada; Hiroshi Hashizume; Makoto Kii; Shinichiro Hara; Sanji Hagishita; Shozo Nakamoto; Katsutoshi Yamada; Yukiko Chikazawa; Masahiko Ueno; Isao Teshirogi; Takashi Ono; Mitsuaki Ohtani

Collaboration


Dive into the Mitsuaki Ohtani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akinori Arimura

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tatsuo Tsuri

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tetsuo Okada

Mukogawa Women's University

View shared research outputs
Top Co-Authors

Avatar

Toshiyuki Kato

Kawasaki Steel Corporation

View shared research outputs
Researchain Logo
Decentralizing Knowledge